发明名称 Therapeutic agent for cancer
摘要 The present invention provides an adjuvant for cancer antigen peptide vaccines and virus antigen peptides, containing a pertussis vaccine as a primary ingredient. The present invention also provides a therapeutic agent for a cancer or viral infectious disease, and a prophylactic agent for metastasis or recurrence of cancer or onset of virus-induced tumor, containing a cancer antigen peptide or virus antigen peptide and a pertussis vaccine. A pertussis vaccine that can be suitably used is a whole cell body pertussis vaccine. The agents of the present invention can be safely administered in a plurality of doses.
申请公布号 US9045556(B2) 申请公布日期 2015.06.02
申请号 US200812449377 申请日期 2008.02.07
申请人 NEC Corporation;The Research Foundation for Microbial Disease of Osaka University;National University Corporation Kochi University 发明人 Udaka Keiko;Ishibashi Masahide
分类号 A61K39/10;A61K39/00;A61K39/04;C07K14/47;A61K39/02 主分类号 A61K39/10
代理机构 Wenderoth, Lind & Ponack, L.L.P. 代理人 Wenderoth, Lind & Ponack, L.L.P.
主权项 1. A therapeutic agent for malignant tumor or a prophylactic agent for malignant tumor metastasis or recurrence, comprising WT1 or a peptide comprising a portion of the amino acid sequence thereof, wherein the peptide consists of the amino acid sequence shown in SEQ ID NO:2 or SEQ ID NO:4, a pertussis vaccine, and a carrier, the pertussis vaccine is a whole cell pertussis vaccine, and the whole cell pertussis vaccine is an adjuvant, wherein the peptide is present in the agent in an amount of 0.1 to 5 mg and the vaccine is present in an amount of 1×108 to 1×109 cells of the whole cell pertussis vaccine.
地址 Tokyo JP